Genprex, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
GNPX on Nasdaq
Location
1601 Trinity Street, Bldg. B, Suite 3.322, Austin, TX

There are no Buy or Sell transactions made by insiders since 11/8/2023

Genprex, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rodney Varner Chairman, President and CEO, Director $1.25M Feb 18, 2024
Ryan Confer Chief Financial Officer $459K Feb 18, 2024
Catherine Vaczy EVP GC Chief Strategy Officer $280K Apr 21, 2023
Mark Berger Chief Medical Officer $258K Feb 18, 2024
Hermant Kumar Chief Mfgr & Tech Officer $211K Feb 18, 2023
Brent Longnecker Director $168K Jun 27, 2023
William R. Wilson Jr. Director $131K Jun 27, 2023
Jose Antonio Moreno Toscano Director $131K Jun 27, 2023

Recent Insider Transactions by Companies or Individuals for Genprex, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.